Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume 26, Issue 3, Pages 285-293
Publisher
Wiley
Online
2017-01-26
DOI
10.1002/pds.4171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies
- (2017) Francesco Salvo et al. PHARMACOLOGICAL RESEARCH
- 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
- (2015) Glenn N. Levine et al. CIRCULATION
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database
- (2015) Julien Bezin et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Effect of adherence to evidence-based therapy after acute myocardial infarction on all-cause mortality
- (2015) Hatem Hamood et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- French health insurance databases: What interest for medical research?
- (2015) G. Moulis et al. REVUE DE MEDECINE INTERNE
- EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
- (2015) Kornelia Kotseva et al. European Journal of Preventive Cardiology
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
- (2014) Ezra A. Amsterdam et al. CIRCULATION
- Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis
- (2013) Dharam J. Kumbhani et al. AMERICAN JOURNAL OF MEDICINE
- Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France
- (2013) J. Bezin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study
- (2013) Anthony S Gunnell et al. HEART
- Effect of evidence-based drug therapy on long-term outcomes in patients discharged after myocardial infarction: a nested case-control study in Italy
- (2013) Ursula Kirchmayer et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2012) et al. EUROPEAN HEART JOURNAL
- Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data
- (2012) Jutta Kuepper-Nybelen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
- (2012) Sripal Bangalore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prediction of persistence of combined evidence-based cardiovascular medications in patients with acute coronary syndrome after hospital discharge using neural networks
- (2011) Valérie Bourdès et al. MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
- Evidence-based pharmacotherapy after myocardial infarction in France: Adherence-associated factors and relationship with 30-month mortality and rehospitalization
- (2010) Philippe Tuppin et al. Archives of Cardiovascular Diseases
- Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies
- (2010) B. H. Ch. Stricker et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Pharmacoepidemiological research using French reimbursement databases: yes we can!
- (2010) Karin Martin-Latry et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- French national health insurance information system and the permanent beneficiaries sample
- (2010) P. Tuppin et al. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
- Immeasurable Time Bias in Observational Studies of Drug Effects on Mortality
- (2008) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
- Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden
- (2008) G. Ringbäck Weitoft et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation